Hair Loss Treatment Type: Dual 5-alpha reductase inhibitor in an oral softgel   Notes: GI197111X is a new dual 5-alpha reductase inhibitor which […]

Abstract Androgenetic alopecia is considered to be associated with coronary heart disease but the explanation of this association remains unknown. […]

How often do you use Nizoral? Every Day Every Other Day Every 3 to 6 Days Every Week Less Than […]

Grow Your Business with the Regrowth Network™ The Regrowth Network has many ways to help you grow your business whether […]

Abstract: TZP-4238 suppresses plasma testosterone in humans, but its action on the androgen biosynthesis pathway has not been established. Therefore, […]

Abstract: Cyclosporin A (CSA) is an immunosuppressive agent that has provided new approaches in transplantation medicine and in the treatment […]

Abstract: We studied the effect of cyclosporin A on human hair growth using a recently described model in which isolated […]

Abstract: We have previously reported that proanthocyanidins extracted from grape seeds possess growth-promoting activity toward murine hair epithelial cells in […]

Abstract: Win 49596 is a new orally active, steroidal androgen receptor antagonist. Win 49596 inhibited ventral prostate, seminal vesicle and […]

Abstract: The effect of TZP-4238, an antiandrogen drug, on renal function was examined. Single administration test: Patients with prostatic hypertrophy […]